Last week, I wrote that there wasn’t enough data yet to support booster doses for people who received Moderna or Janssen vaccine. That may be changing soon, and possibly as soon as this week.
The FDA has scheduled a 2-day meeting of its Vaccines and Related Biological Products Advisory Committee – the same independent advisory group to the FDA that reviewed initial data on COVID-19 vaccines – on Thursday, October 14 and Friday, October 15 to discuss booster doses of Moderna and Janssen vaccines. Should you rush on out and schedule an appointment for a Moderna or Janssen booster dose this weekend? Not necessarily; it means that the companies have submitted enough data to justify convening a meeting to discuss it.
Still, this pandemic is evolving quickly and it’s entirely possible to have insufficient evidence one week and compelling evidence a few weeks later. I look forward to seeing whatever data the FDA shares later this week.
Stay healthy,
😷 Dr. B